does tirzepatide cause osteoporosis Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites Frontiers | Bone mineral density

Its all about Ozempic & Wegovy for Europes largest company Novo Nordisk, the pharma giant thats become even more giant thanks to its weight loss drugs Ozempic and Wegovy , reported first-quarter earnings yesterday

The central mechanism is angiogenesis: the peptide upregulates vascular endothelial growth factor (VEGF) and drives new blood-vessel formation at injury sites, which brings oxygen and nutrients to healing tissue

Efficacy and Safety of Retatrutide in the Treatment of Diabetes and/or Obesity Comorbid with Chronic Kidney Disease: a Systematic Review and Meta-Analysis

J Am Pharm Assoc S1544-3191(23)00309-6

(P50 AA024333, RF1 NS133812, R01 DK130227, R01 DK120679, P01 HL147823, and DOD KC2210163 to J.M.B.)

Weight Loss Is Not the Only Outcome That Matters A major mistake in weight loss medicine is focusing only on pounds lost